Olympus 2007 Annual Report Download - page 19

Download and view the complete annual report

Please find page 19 of the 2007 Olympus annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 62

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62

Others
Business
Sales
(Millions of yen)
64,377
32,372
06 07
32,005
64,446
32,792
31,654 Overseas
sales
Domestic
sales
> In the Others business, Olympus mainly engages in the man-
ufacture and sale of industrial endoscopes, non-destructive
testing devices, printers and bar code scanners, as well as
system development.
Sales in the Others business edged down 0.1% to
¥64,377 million (US$536 million) and operating income
fell 39.6% to ¥872 million (US$7 million).
Olympus recorded a significant sales increase in indus-
trial videoscopes as well as ultrasonic/eddy current flaw
detectors for checking and assessment of structural objects.
Olympus’ compact, lightweight ultrasonic/eddy current
flaw detectors were very well accepted in the market,
drawing increased demand for visual testing applications,
an area that especially requires system mobility. Sales of
phased array instruments also rose sharply, meeting needs
for more accurate and speedy inspections. These factors
underpinned significant overall year-on-year sales growth
in the non-destructive testing devices field.
> In the information equipment field, Olympus recorded an
increase in shipments of printers being manufactured in col-
laboration with Riso Kagaku Corporation. Sales in the bio-
medical materials field increased, supported by favorable
sales of both newly launched and existing bone replace-
ment materials. Overall sales in the Others business were
flat as a result of protracted sales of investment securities
Others
2.
BONE REPLACEMENT
MATERIAL (GRANULE-TYPE
WITH 60% POROSITY)
OSferion
60
This artificial bone
replacement material
containsβ-tricalcium
phosphate for enhanced
mechanical strength.
for business incubation by ITX Corporation. Operating
income also declined owing to a drop in proceeds on sales
of investment securities.
Outlook for
Fiscal 2008
> Olympus is forecasting increased sales and profits in the
Others business in expectation of stronger sales of non-
destructive testing devices. In April 2007, Olympus opened
a new chapter in its biomedical materials: the operations
of Olympus Biomaterial Corporation, a consolidated sub-
sidiary engaged in the biomedical materials and regenera-
tive medicine businesses, were merged with the collagen
business of Terumo Corporation. Accordingly, Olympus
and Terumo Corporation formed the joint venture company
Olympus Terumo Biomaterials Corp. This new joint ven-
ture company will integrate the technologies of the two
companies. Looking forward, Olympus plans to expand
its biomedical materials business across a range of areas,
including orthopedic surgery, dental and oral surgery, cos-
metic surgery, and dermatology, with a goal of reaching
¥5.0 billion in sales three years from now. In the Others
business, fiscal 2008 forecasts are for sales of ¥72.0 bil-
lion and operating income of ¥1.5 billion.
1.
PHASED ARRAY
INSTRUMENT
OmniScan
MX PA
A high-speed data
collection rate and powerful
software features realize
efficient manual and
automated inspections.
OLYMPUS 2007 17
01-24.indd 1701-24.indd 17 07.8.3 0:16:37 PM07.8.3 0:16:37 PM